摘要
目的:探讨奥美沙坦及硝苯地平控释片治疗原发性高血压的疗效。方法:收治原发性高血压患者80例,分为对照组和观察组。观察组采用奥美沙坦及硝苯地平控释片治疗,对照组采用奥美沙坦治疗,比较两组治疗效果。结果:治疗后两组DBP和SBP均有所改善,但观察组改善更为明显(P<0.05);两组不良反应发生率差异无统计学意义(P>0.05)。结论:奥美沙坦及硝苯地平控释片治疗原发性高血压降压效果显著,且安全性较高。
Objective:To explore the efficacy of olmesartan and nifedipine controlled release tablets in the treatment of primary hypertension.Methods:80 patients with primary hypertension were selected.They were divided into the control group and the observation group.The observation group was treated with olmesartan and nifedipine controlled release tablets,and the control group was treated with olmesartan.We compared the therapeutic effect of the two groups.Results:After treatment,the DBP and SBP in the two groups were improved,but the improvement in the observation group was more significant(P〈0.05).There was no significant difference in the incidence of adverse reactions between groups(P〈0.05).Conclusion:The efficacy of olmesartan and nifedipine controlled release tablets in the treatment of primary hypertension was significant,and the security was high.
作者
常青
Chang Qing(Gushan Health Center of Jiangyin City(Jiangsu)214413)
出处
《中国社区医师》
2018年第19期16-16,18,共2页
Chinese Community Doctors
关键词
奥美沙坦
硝苯地平控释片
原发性高血压
Olmesartan
Nifedipine controlled release tablets
Primary hypertension